Drug major Lupin on Tuesday said it has received approval from the US health regulator for its Albuterol Sulfate Inhalation Aerosol, used for the treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms.
Homegrown pharma major Lupin Ltd on Thursday said it has launched its generic version of Vimovo tablets, used for relief from arthritis, in the US market.
Drug maker Lupin on Monday said the US health regulator made two observations after inspection of its Goa plant and cautioned that the facility may be subject to regulatory action and it may withhold approval of pending applications in which this facility is listed.
New Delhi: Lupin, India's fourth-largest drugmaker by sales, will buy US-based Gavis Pharmaceuticals for USD 880 million (Rs 5,610 crore) - its largest acquisition as the company looks to expand in the US generics market.The
New Delhi: Drug firm Lupin has launched in the US market the generic version of Celebrex capsules used for the treatment of osteoarthritis, rheumatoid arthritis and acute pain.Its US subsidiary, Lupin Pharmaceuticals Inc, has launched
New Delhi: Drug firm Lupin today said it has received approval from the U.S. health regulator to market generic version of GD Searle LLC's Celebrex capsules, used to treat arthritis, in the American market.The Mumbai-based
Los Angeles: Actor Daniel Radcliffe finds Sirius Black as his favourite character from the popular film franchise "Harry Potter", which made him a global star.The 25-year-old actor says that while he always liked the character,
Chandigarh: Pharma major Venus Remedies Ltd today said it has received marketing authorisation for its antibiotic drug Meropenem from Australian regulator TGA and has tied up with Lupin to sell the drug there.The Panchkula-based company
New Delhi: Drug major Lupin today acquired Mexico's Laboratorios Grin, a leading player in ophthalmic products, for an undisclosed amount, marking its foray into the Latin American country. The company said it has acquired 100
New Delhi, May 8: Drug major Lupin has posted nearly three-fold increase in its consolidated net profit at Rs. 408.1 crore for the fourth quarter ended March 31, 2013. The Mumbai-based firm had posted a
Top News
Latest News
